0000899243-22-027629.txt : 20220803
0000899243-22-027629.hdr.sgml : 20220803
20220803174530
ACCESSION NUMBER: 0000899243-22-027629
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220803
DATE AS OF CHANGE: 20220803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Habibizad Nazila
CENTRAL INDEX KEY: 0001913961
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37539
FILM NUMBER: 221133898
MAIL ADDRESS:
STREET 1: C/O GLOBAL BLOOD THERAPEUTICS, INC.
STREET 2: 181 OYSTER POINT BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc.
CENTRAL INDEX KEY: 0001629137
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274825712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 181 OYSTER POINT BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650741-7700
MAIL ADDRESS:
STREET 1: 181 OYSTER POINT BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
3/A
1
doc3a.xml
FORM 3/A SUBMISSION
X0206
3/A
2022-03-01
2022-03-03
0
0001629137
Global Blood Therapeutics, Inc.
GBT
0001913961
Habibizad Nazila
C/O GLOBAL BLOOD THERAPEUTICS, INC.
181 OYSTER POINT BOULEVARD.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
See Remarks
Common Stock
10528
D
Amendment filed to correct the number of shares reported as beneficially owned by the Reporting Person on her original Form 3, which inadvertently overstated the number of shares held. The overstatement was carried forward on the Reporting Person's subsequent filed Forms 4.
Executive Vice President, Operations
/s/ Miguel Carrillo, Attorney-in-Fact
2022-08-03